(Q36997857)

17 August 2017

1 reference

title

Hairy cell leukaemia: the role of alpha interferon (English)

1 reference

17 August 2017

Hairy cell leukaemia: The role of alpha interferon (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

28 November 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

28 November 2022

author name string

L. C. Platanias

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799481

28 November 2022

M. J. Ratain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799481

28 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1799481

28 November 2022

publication date

1 January 1991

1 reference

full work available at URL

17 August 2017

https://api.elsevier.com/content/article/PII:027753799190575X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

https://api.elsevier.com/content/article/PII:027753799190575X?httpAccept=text/plain

28 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

European Journal of Cancer

28 November 2022

published in

1 reference

17 August 2017

27 Suppl 4

1 reference

17 August 2017

S53-7

1 reference

Hairy cell leukemia: a clinical review based on 71 cases

17 August 2017

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

The history of hairy cell leukemia: characteristics of long-term survivors

28 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia

28 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

The nature of hairy cells - a study with a panel of monoclonal antibodies.

28 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Recent advances in the treatment of hairy-cell leukemia

28 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

What is the choice of treatment for hairy cell leukemia?

28 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Prognostic variables in hairy cell leukemia after splenectomy as initial therapy

28 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Alpha interferon for induction of remission in hairy-cell leukemia

28 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Biochemistry of Interferons and Their Actions

28 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Effects of interferon on differentiation of normal and tumor cells

28 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Studies of interferon as a regulator of hematopoietic cell proliferation

28 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Human recombinant interferon alpha-2C enhances the expression of class II HLA antigens on hairy cells

28 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

B cell growth factor-induced proliferation of hairy cell lymphocytes and inhibition by type I interferon in vitro

28 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies

28 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Treatment of hairy cell leukemia with recombinant alpha 2 interferon

28 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Recombinant alpha-2-interferon for hairy cell leukemia

28 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients

28 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic results

28 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables

28 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Low-dose interferon alfa-2b in the treatment of hairy cell leukemia

28 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia

28 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies

28 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Clinical significance of anti-IFN-alpha antibody titres during interferon therapy

28 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection

28 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Interferon Alfa-2b Antibodies and Clinical Resistance in a Patient with Hairy Cell Leukemia

28 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodies

28 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin)

28 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin)

28 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group

28 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Pentostatin in the treatment of advanced hairy cell leukemia

28 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Pentostatin in hairy cell leukemia: treatment by the special exception mechanism

28 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine

28 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes

28 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90575-X

28 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1799481

28 November 2022

1 reference